Eli

CEO of Eli Lilly and Company David Ricks speaks at the Economic Club of New York on March 12, 2024 in New York City. Spencer Platt | Getty ImagesEli Lilly CEO Dave Ricks on Thursday said the drugmaker can help "respond" to national…

Eli Lilly on Thursday reported first-quarter revenue and earnings that topped estimates as demand for its weight loss and diabetes drugs soared, but lowered its full-year profit guidance due to charges related to a recent cancer…

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersEli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's…

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight and showing safety comparable with popular…

The Eli Lilly logo is shown on one of the company's offices in San Diego, California, on Sept. 17, 2020.Mike Blake | ReutersEli Lilly is suing two pharmacies for compounding Zepbound and Mounjaro, claiming the companies are skirting the…

A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty ImagesPatients, doctors and investors will soon learn a lot more about a new, more convenient…

Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes injections soars and the company develops new drugs for other…

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersEli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as…

The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg | Getty ImagesEli Lilly cut its revenue guidance on Tuesday as it said demand for its…

David Ricks, CEO, Eli LillyScott Mlyn | CNBCEli Lilly expects its experimental weight loss pill will get approved as soon as early next year, CEO David Ricks told Bloomberg TV on Monday.The company is set to release key late-stage trial…